Novel intravenous (IV) vectorized antibody approach designed to activate innate immune system, destroy metastatic breast cancer tumors, and inhibit tumor progression in CNS Proprietary TRACER™  capsid screening technology enables broad expression of vectorized antibody in mouse brain TRACER AAV